Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21417952 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses
Conditions: Renal Insufficiency, Chronic;   Deep Venous Thrombosis, Protection Against
Intervention: Drug: Tinzaparin
2 Completed PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
Conditions: Critical Illness;   Deep Venous Thrombosis
Interventions: Drug: LMWH (Fragmin, dalteparin);   Drug: Unfractionated Heparin

Indicates status has not been verified in more than two years